Veterinary Medicines

Carprieve 100 mg Tablets for Dogs

Authorised
  • Carprofen
Download as PDF

Product identification

Medicine name:
Carprieve 100 mg Tablets for Dogs
Carprieve 100 mg Tablets for Dogs
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    100.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Available in:
  • United Kingdom (Northern Ireland)
Package description:
  • Polypropylene Snap Secure Tubs containing 14 tablets, sealed with a white low density Polyethylene Snap SecureCap
  • Polypropylene Snap Secure Tubs containing 30 tablets, sealed with a white low density Polyethylene Snap SecureCap
  • Polypropylene Snap Secure Tubs containing 100 tablets, sealed with a white low density Polyethylene Snap SecureCap
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 10 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 20 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 30 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 50 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 60 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 70 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 100 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 140 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 180 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 200 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 250 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 280 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 300 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 500 tablets
  • Aluminium-Aluminium blister strips of 10 tablets in cartons containing 1000 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Norbrook Laboratories Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Ltd
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 02000/4283
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0550/001
Concerned member states:
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download